A citation-based method for searching scientific literature


List of co-cited articles
479 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.
Yiqing Yan, Wei Jiang, Lei Liu, Xiaqiong Wang, Chen Ding, Zhigang Tian, Rongbin Zhou. Cell 2015
489
26

Dopaminergic Regulation of Innate Immunity: a Review.
Monica Pinoli, Franca Marino, Marco Cosentino. J Neuroimmune Pharmacol 2017
54
22

Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study.
F McKenna, P J McLaughlin, B J Lewis, G C Sibbring, J A Cummerson, D Bowen-Jones, R J Moots. J Neuroimmunol 2002
192
20

The immunoregulatory role of dopamine: an update.
Chandrani Sarkar, Biswarup Basu, Debanjan Chakroborty, Partha Sarthi Dasgupta, Sujit Basu. Brain Behav Immun 2010
177
20


Dopamine receptors - IUPHAR Review 13.
Jean-Martin Beaulieu, Stefano Espinoza, Raul R Gainetdinov. Br J Pharmacol 2015
239
20


Immunomodulatory Effects Mediated by Dopamine.
Rodrigo Arreola, Samantha Alvarez-Herrera, Gilberto Pérez-Sánchez, Enrique Becerril-Villanueva, Carlos Cruz-Fuentes, Enrique Octavio Flores-Gutierrez, María Eugenia Garcés-Alvarez, Dora Luz de la Cruz-Aguilera, Emilio Medina-Rivero, Gabriela Hurtado-Alvarado,[...]. J Immunol Res 2016
60
18

Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse.
Peter J Gaskill, Loreto Carvallo, Eliseo A Eugenin, Joan W Berman. J Neuroinflammation 2012
57
18

The role of catecholamines in HIV neuropathogenesis.
R Nolan, P J Gaskill. Brain Res 2019
22
36

The physiology, signaling, and pharmacology of dopamine receptors.
Jean-Martin Beaulieu, Raul R Gainetdinov. Pharmacol Rev 2011
16

Targeting the Dopaminergic System in Autoimmunity.
Pia M Vidal, Rodrigo Pacheco. J Neuroimmune Pharmacol 2020
25
32

Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.
Wei Shao, Shu-zhen Zhang, Mi Tang, Xin-hua Zhang, Zheng Zhou, Yan-qing Yin, Qin-bo Zhou, Yuan-yuan Huang, Ying-jun Liu, Eric Wawrousek,[...]. Nature 2013
241
14

Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity.
Carolina Prado, Francisco Contreras, Hugo González, Pablo Díaz, Daniela Elgueta, Magaly Barrientos, Andrés A Herrada, Álvaro Lladser, Sebastián Bernales, Rodrigo Pacheco. J Immunol 2012
85
14


Dopamine, a neurotransmitter, influences the immune system.
S Basu, P S Dasgupta. J Neuroimmunol 2000
210
12

Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.
Marco Cosentino, Anna Maria Fietta, Marco Ferrari, Emanuela Rasini, Raffaella Bombelli, Elena Carcano, Federica Saporiti, Federica Meloni, Franca Marino, Sergio Lecchini. Blood 2007
197
12

Dopamine released by dendritic cells polarizes Th2 differentiation.
Kazuhisa Nakano, Takehiro Higashi, Rie Takagi, Kumiko Hashimoto, Yoshiya Tanaka, Sho Matsushita. Int Immunol 2009
92
12

Subcortical brain atrophy persists even in HAART-regulated HIV disease.
James T Becker, Joanne Sanders, Sarah K Madsen, Ann Ragin, Lawrence Kingsley, Victoria Maruca, Bruce Cohen, Karl Goodkin, Eileen Martin, Eric N Miller,[...]. Brain Imaging Behav 2011
127
12

Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.
Peter J Gaskill, Tina M Calderon, Jacqueline S Coley, Joan W Berman. J Neuroimmune Pharmacol 2013
46
13

Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.
Peter J Gaskill, Tina M Calderon, Aimée J Luers, Eliseo A Eugenin, Jonathan A Javitch, Joan W Berman. Am J Pathol 2009
83
12

Dopamine receptor activation increases HIV entry into primary human macrophages.
Peter J Gaskill, Hideaki H Yano, Ganjam V Kalpana, Jonathan A Javitch, Joan W Berman. PLoS One 2014
43
13



Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity.
Francisco Contreras, Carolina Prado, Hugo González, Dafne Franz, Francisco Osorio-Barrios, Fabiola Osorio, Valentina Ugalde, Ernesto Lopez, Daniela Elgueta, Alicia Figueroa,[...]. J Immunol 2016
41
14

Substantial production of dopamine in the human gastrointestinal tract.
G Eisenhofer, A Aneman, P Friberg, D Hooper, L Fåndriks, H Lonroth, B Hunyady, E Mezey. J Clin Endocrinol Metab 1997
195
10

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.
Natasa Kustrimovic, Emanuela Rasini, Massimiliano Legnaro, Raffaella Bombelli, Iva Aleksic, Fabio Blandini, Cristoforo Comi, Marco Mauri, Brigida Minafra, Giulio Riboldazzi,[...]. Sci Rep 2016
49
10


The AIDS dementia complex: II. Neuropathology.
B A Navia, E S Cho, C K Petito, R W Price. Ann Neurol 1986
10

CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.
Anjana Yadav, Ronald G Collman. J Neuroimmune Pharmacol 2009
137
10

De novo expression of dopamine D2 receptors on microglia after stroke.
Jojanneke H J Huck, Dorette Freyer, Chotima Böttcher, Mihovil Mladinov, Claudia Muselmann-Genschow, Mareike Thielke, Nadine Gladow, Dana Bloomquist, Philipp Mergenthaler, Josef Priller. J Cereb Blood Flow Metab 2015
53
10


HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.
Deanna Saylor, Alex M Dickens, Ned Sacktor, Norman Haughey, Barbara Slusher, Mikhail Pletnikov, Joseph L Mankowski, Amanda Brown, David J Volsky, Justin C McArthur. Nat Rev Neurol 2016
378
10

Dopamine and noradrenaline control distinct functions in rodent microglial cells.
Katrin Färber, Ulrike Pannasch, Helmut Kettenmann. Mol Cell Neurosci 2005
155
10

Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.
Mikhail Melnikov, Vladimir Rogovskii, Alexey Boykо, Mikhail Pashenkov. J Neuroimmune Pharmacol 2020
16
31

Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.
E A Nickoloff-Bybel, P Mackie, K Runner, S M Matt, H Khoshbouei, P J Gaskill. Brain Behav Immun 2019
6
83

Dopamine: Functions, Signaling, and Association with Neurological Diseases.
Marianne O Klein, Daniella S Battagello, Ariel R Cardoso, David N Hauser, Jackson C Bittencourt, Ricardo G Correa. Cell Mol Neurobiol 2019
127
10

Dopamine Alters Lipopolysaccharide-Induced Nitric Oxide Production in Microglial Cells via Activation of D1-Like Receptors.
Biao Wang, Teng Chen, Guodong Li, Yuwei Jia, Jing Wang, Li Xue, Yanjiong Chen. Neurochem Res 2019
12
41

Microglial responses to dopamine in a cell culture model of Parkinson's disease.
Diego Mastroeni, Andrew Grover, Brian Leonard, Jeffrey N Joyce, Paul D Coleman, Brooke Kozik, Denise L Bellinger, Joseph Rogers. Neurobiol Aging 2009
69
10

Complexity of dopamine metabolism.
Johannes Meiser, Daniel Weindl, Karsten Hiller. Cell Commun Signal 2013
260
10

Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis.
Kazuhisa Nakano, Takehiro Higashi, Kumiko Hashimoto, Rie Takagi, Yoshiya Tanaka, Sho Matsushita. Biochem Biophys Res Commun 2008
103
10

Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.
Jonathan Kipnis, Michal Cardon, Hila Avidan, Gil M Lewitus, Sharon Mordechay, Asya Rolls, Yael Shani, Michal Schwartz. J Neurosci 2004
130
10

DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling.
A L Northcutt, M R Hutchinson, X Wang, M V Baratta, T Hiranita, T A Cochran, M B Pomrenze, E L Galer, T A Kopajtic, C M Li,[...]. Mol Psychiatry 2015
118
10



Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation.
Kazuyuki Nakagome, Mitsuru Imamura, Hirokazu Okada, Kimito Kawahata, Tsutomu Inoue, Kumiko Hashimoto, Hiroaki Harada, Takehiro Higashi, Rie Takagi, Kazuhisa Nakano,[...]. J Immunol 2011
51
8

Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model.
Kazuhisa Nakano, Kunihiro Yamaoka, Kentaro Hanami, Kazuyoshi Saito, Yasuyuki Sasaguri, Nobuyuki Yanagihara, Shinya Tanaka, Ichiro Katsuki, Sho Matsushita, Yoshiya Tanaka. J Immunol 2011
78
8

Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
Hugo González, Francisco Contreras, Carolina Prado, Daniela Elgueta, Dafne Franz, Sebastián Bernales, Rodrigo Pacheco. J Immunol 2013
93
8

HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study.
Jonathan C Ipser, Gregory G Brown, Amanda Bischoff-Grethe, Colm G Connolly, Ronald J Ellis, Robert K Heaton, Igor Grant. J Int Neuropsychol Soc 2015
47
8

Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years.
Katherine M Clifford, Vishal Samboju, Yann Cobigo, Benedetta Milanini, Gabriel A Marx, Joanna M Hellmuth, Howard J Rosen, Joel H Kramer, Isabel E Allen, Victor G Valcour. J Acquir Immune Defic Syndr 2017
41
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.